KATHERINE LEE: Open Payments
NPI 1932546652 · ELMHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,783 in 75 payments from 13 companies in 2025. Trend: 2023 $1,623 · 2024 $1,894 · 2025 $1,783
Food & beverage: $1,774Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $410 |
| ABBVIE INC. | 12 | $317 |
| GENZYME CORPORATION | 7 | $270 |
| Incyte Corporation | 12 | $173 |
| LEO Pharma Inc. | 10 | $152 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| UCB, Inc. | 3 | $79 |
| Galderma Laboratories, L.P. | 2 | $70 |
| Lilly USA, LLC | 3 | $69 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $61 |
Products named: TREMFYA, DUPIXENT, RINVOQ, OPZELURA, SKYRIZI, ANZUPGO, Bimzelx, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
